In a recent study published in JAMA Network Open, researchers found that the “stiff heart” heart failure variant accounts for about half of all cases and most of the patients take beta-blocker medications despite unclear benefits from their regular use.
The finding links the use of beta-blockers to heart failure hospitalizations among those with this common “stiff heart” heart failure subtype.
The study is from the University of Vermont. One author is Timothy Plante, M.D.
Nearly six million Americans have heart failure, a leading driver of health care costs in the United States. Heart failure occurs when the heart cannot meet the body’s demands.
About half of patients have heart failure characterized by a normal squeeze but impaired relaxation of the heart muscle from a “stiff heart”.
This is also known as heart failure with preserved ejection fraction. The other half of cases are due to a “weak heart” with an abnormal squeeze, also known as heart failure with reduced ejection fraction.
Beta-blockers—medications that lower the heart rate and blood pressure—are strongly recommended in national guidelines for the treatment of “weak heart” heart failure because of their clear benefit.
According to the team, a big problem with ‘stiff heart’ heart failure is that doctors don’t have effective medical therapies.
So, instead, they use the same medications that work for ‘weak heart’ heart failure.
Because beta-blockers save lives in ‘weak heart’ heart failure, doctors assume they are also effective in ‘stiff heart’ heart failure patients—this assumption may be wrong.
The researchers analyzed data from the National Institutes of Health-funded TOPCAT study.
It was a trial of the medication spironolactone in patients with “stiff heart” heart failure. About four out of five study participants were on beta-blockers.
The researchers found beta-blocker use to be a risk factor for hospitalizations for heart failure among these patients with “stiff heart” heart failure.
Beta-blocker use was linked to a 74% higher risk of heart failure hospitalizations among participants with heart failure and a normal pump function.
The team says in ‘stiff heart’ heart failure, the heart is less able to relax and fill with blood. Beta-blockers appear to increase pressures inside the heart.
This may lead to symptoms like worsening shortness of breath and retention of fluid
Despite their common use, the researchers note that beta-blocker use in “stiff heart” heart failure has not been sufficiently studied.
If you care about heart health, please read studies about an easy way to prevent heart disease, reduce cholesterol and the findings of this diabetes drug may harm your heart health.
For more information about heart disease prevention and treatment, please see recent studies about two effective ways to quickly restore normal heart rhythm and results showing that this type of work linked to high risk of heart disease, stroke and type 2 diabetes.
Copyright © 2021 Knowridge Science Report. All rights reserved.
